Curative Biosciences (Curative Biosciences) Debt-to-Equity : -0.48 (As of Mar. 2018)

Curative Biosciences Debt-to-Equity Chart

Curative Biosciences Annual Data
	Trend	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17
Debt-to-Equity		Get a 7-Day Free Trial					-	-	-	-0.08	-0.10

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Debt-to-Equity	Get a 7-Day Free Trial															-	-0.10	-	-	-0.48

Competitive Comparison of Curative Biosciences's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Debt-to-Equity falls into.

Curative Biosciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Curative Biosciences's Debt to Equity Ratio for the fiscal year that ended in Jun. 2017 is calculated as

Curative Biosciences's Debt to Equity Ratio for the quarter that ended in Mar. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences  (OTCPK:CBDX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Curative Biosciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biosciences (Curative Biosciences) Business Description